Berglund J - Search Results

1

Oesophageal disease revealed by endoscopy in 1,000 patients referred primarily for gastroscopy.

Cronstedt J, Carling L, Vestergaard P, Berglund J. Cronstedt J, et al. Among authors: berglund j. Acta Med Scand. 1978;204(5):413-6. doi: 10.1111/j.0954-6820.1978.tb08464.x. Acta Med Scand. 1978. PMID: 102120

2

Metabolic and blood pressure monitoring in diabetic renal failure.

Berglund J, Lins LE, Lins PE. Berglund J, et al. Acta Med Scand. 1985;218(4):401-8. doi: 10.1111/j.0954-6820.1985.tb08865.x. Acta Med Scand. 1985. PMID: 4083082

3

Microalbuminuria in long-term insulin-dependent diabetes mellitus. Prevalence and clinical characteristics in a normotensive population.

Berglund J, Lins PE, Adamson U, Lins LE. Berglund J, et al. Acta Med Scand. 1987;222(4):333-8. doi: 10.1111/j.0954-6820.1987.tb10680.x. Acta Med Scand. 1987. PMID: 3425386

4

Hemodynamics in diabetic renal failure.

Berglund J, Jonasson R, Pehrsson SK. Berglund J, et al. Acta Med Scand. 1985;218(1):97-104. doi: 10.1111/j.0954-6820.1985.tb08831.x. Acta Med Scand. 1985. PMID: 4050555

5

Predictability in diabetic nephropathy.

Berglund J, Lins LE, Lins PE. Berglund J, et al. Acta Med Scand. 1984;215(3):263-70. doi: 10.1111/j.0954-6820.1984.tb05004.x. Acta Med Scand. 1984. PMID: 6731039

6

Studies of cardiovascular and renal function in subclinical and manifest diabetic nephropathy.

Berglund J. Berglund J. Acta Med Scand Suppl. 1988;722:1-69. Acta Med Scand Suppl. 1988. PMID: 3163465

7

Efficacy and tolerability of hydralazine, in conventional and slow-release preparations, during long-term treatment of primary hypertension.

Lins LE, Berglund J, Eliasson K, Wernersson B. Lins LE, et al. Among authors: berglund j. Clin Ther. 1983;5(3):251-9. Clin Ther. 1983. PMID: 6850719

8

[Synergistic effect of furosemide and metolazone in edema cases difficult to handle].

Jacobson S, Berglund J, Lins LE. Jacobson S, et al. Among authors: berglund j. Lakartidningen. 1987 Mar 11;84(11):846. Lakartidningen. 1987. PMID: 3561104 Swedish. No abstract available.

9

New Horizons in Myotonic Dystrophy Type 1: Cellular Senescence as a Therapeutic Target.

Légaré C, Berglund JA, Duchesne E, Dumont NA. Légaré C, et al. Among authors: berglund ja. Bioessays. 2024 Dec 26:e202400216. doi: 10.1002/bies.202400216. Online ahead of print. Bioessays. 2024. PMID: 39723693 Review.

10

Dysregulation of alternative splicing is a transcriptomic feature of patient-derived fibroblasts from CAG repeat expansion spinocerebellar ataxias.

Aliyeva A, Lennon CD, Cleary JD, Shorrock HK, Berglund JA. Aliyeva A, et al. Among authors: berglund ja. Hum Mol Genet. 2024 Nov 26:ddae174. doi: 10.1093/hmg/ddae174. Online ahead of print. Hum Mol Genet. 2024. PMID: 39589088

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

358 results

Search Page

Filters